Risk profiles for heavy drinking in adolescence: differential effects of gender.


Journal

Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935

Informations de publication

Date de publication:
07 2019
Historique:
received: 01 12 2017
revised: 20 04 2018
accepted: 23 04 2018
pubmed: 31 5 2018
medline: 11 8 2020
entrez: 31 5 2018
Statut: ppublish

Résumé

Abnormalities across different domains of neuropsychological functioning may constitute a risk factor for heavy drinking during adolescence and for developing alcohol use disorders later in life. However, the exact nature of such multi-domain risk profiles is unclear, and it is further unclear whether these risk profiles differ between genders. We combined longitudinal and cross-sectional analyses on the large IMAGEN sample (N ≈ 1000) to predict heavy drinking at age 19 from gray matter volume as well as from psychosocial data at age 14 and 19-for males and females separately. Heavy drinking was associated with reduced gray matter volume in 19-year-olds' bilateral ACC, MPFC, thalamus, middle, medial and superior OFC as well as left amygdala and anterior insula and right inferior OFC. Notably, this lower gray matter volume associated with heavy drinking was stronger in females than in males. In both genders, we observed that impulsivity and facets of novelty seeking at the age of 14 and 19, as well as hopelessness at the age of 14, are risk factors for heavy drinking at the age of 19. Stressful life events with internal (but not external) locus of control were associated with heavy drinking only at age 19. Personality and stress assessment in adolescents may help to better target counseling and prevention programs. This might reduce heavy drinking in adolescents and hence reduce the risk of early brain atrophy, especially in females. In turn, this could additionally reduce the risk of developing alcohol use disorders later in adulthood.

Identifiants

pubmed: 29847018
doi: 10.1111/adb.12636
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

787-801

Subventions

Organisme : the National Institutes of Health, Science Foundation Ireland
ID : 16/ERCD/3797
Pays : International
Organisme : Paris Sud University IDEX 2012
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC 257 FOR 1617 GRK 1589/2 HE2597/14-2SFB 940/1SM 80/7-1SM 80/7-2
Pays : International
Organisme : European Union-funded FP6 Integrated Project IMAGEN
ID : LSHM-CT-2007-037286
Pays : International
Organisme : Horizon 2020 funded ERC Advanced Grant 'STRATIFY'
ID : 695313
Pays : International
Organisme : German Research Foundation
ID : GRK 1589/2
Pays : International
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : Assistance-Publique-Hôpitaux-de-Paris and INSERM
Pays : International
Organisme : NIH Consortium
ID : U54 EB020403
Pays : International
Organisme : BRIDGET
ID : MR/N027558/1
Pays : International
Organisme : Axon, Testosterone and Mental Health during Adolescence
ID : RO1 MH085772-01A1
Pays : International
Organisme : FP7 projects IMAGEMEND
ID : 602450
Pays : International
Organisme : National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
Pays : International
Organisme : Bundesministeriumfür Bildung und Forschung
ID : 01EV0711
Pays : International
Organisme : Bundesministeriumfür Bildung und Forschung
ID : 01GS08152
Pays : International
Organisme : Fondation de France
Pays : International
Organisme : Horizon 2020 Framework Programme
ID : 695313MR/N027558/1PR-ST-0416-10004
Pays : International
Organisme : MATRICS
ID : 603016
Pays : International
Organisme : Innovative Medicine Initiative Project EU-AIMS
ID : 115300-2
Pays : International
Organisme : U.S.A.
ID : RO1 MH085772-01A1
Pays : International
Organisme : German Research Foundation
ID : EXC 257
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB 940/1
Pays : International
Organisme : ANR
ID : ANR-12-SAMA-0004
Pays : International
Organisme : the Assistance-Publique-Hôpitaux-de-Paris and INSERM
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : SM 80/7-1
Pays : International
Organisme : ERANID
ID : PR-ST-0416-10004
Pays : International
Organisme : German Ministry for Education and Research
ID : BMBF 01ZX1311D/
Pays : International
Organisme : Swedish Research Council FORMAS
Pays : International
Organisme : Fondation de France, the Fondation pour la Recherche Médicale
Pays : International
Organisme : Bundesministerium für Bildung und Forschung
ID : 01EV071101GS0815201ZX1311A01ZX1311D/E 01ZX1611D/E
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : SM 80/7-2
Pays : International
Organisme : Fondation pour la Recherche Médicale, the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives
ID : MILDECA
Pays : International
Organisme : National Institutes of Health, Science Foundation Ireland
ID : 16/ERCD/3797
Pays : International
Organisme : Medical Research Council Grant 'c-VEDA'
ID : MR/N000390/1
Pays : International
Organisme : Swedish Research Council
ID : FORMAS
Pays : International
Organisme : DFG FOR 1617
ID : HE2597/14-2
Pays : International
Organisme : Paris Sud University
ID : IDEX 2012
Pays : International
Organisme : ANR
ID : AF12-NEUR0008-01-WM2NA
Pays : International
Organisme : Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA)
Pays : International
Organisme : German Ministry for Education and Research
ID : BMBF 01ZX1611D/E
Pays : International

Informations de copyright

© 2018 Society for the Study of Addiction.

Auteurs

Sambu Seo (S)

Neural Information Processing Group, Department of Computer Science and Electrical Engineering, Technische Universität Berlin, and Bernstein Center for Computational Neuroscience, Germany.

Anne Beck (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Germany.

Caroline Matthis (C)

Neural Information Processing Group, Department of Computer Science and Electrical Engineering, Technische Universität Berlin, and Bernstein Center for Computational Neuroscience, Germany.

Alexander Genauck (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Germany.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland.

Uli Bromberg (U)

Department of Systems Neuroscience, University Medical Centre Hamburg-Eppendorf, Germany.

Christian Büchel (C)

Department of Systems Neuroscience, University Medical Centre Hamburg-Eppendorf, Germany.

Erin Burke Quinlan (EB)

Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, Germany.

Vincent Frouin (V)

NeuroSpin, CEA, Université Paris-Saclay, France.

Hugh Garavan (H)

Departments of Psychiatry and Psychology, University of Vermont, USA.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, UK.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 'Neuroimaging and Psychiatry', University Paris Sud-Paris Saclay, University Paris Descartes, Service Hospitalier Frédéric Joliot, Orsay and Maison de Solenn, France.

Marie-Laure Paillère Martinot (ML)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 'Neuroimaging and Psychiatry', University Paris Sud-Paris Saclay, University Paris Descartes and AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.

Dimitri Papadopoulos Orfanos (D)

NeuroSpin, CEA, Université Paris-Saclay, France.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Germany.

Sarah Hohmann (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Ireland.

Sylvane Desrivières (S)

Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Germany.

Gunter Schumann (G)

Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Klaus Obermayer (K)

Neural Information Processing Group, Department of Computer Science and Electrical Engineering, Technische Universität Berlin, and Bernstein Center for Computational Neuroscience, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH